Switch to:
More From Other Websites
How traders are protecting Mylan Dec 19 2014
Mylan to Present at the J.P. Morgan 33rd Annual Healthcare Conference Dec 17 2014
Mylan to Present at the J.P. Morgan 33rd Annual Healthcare Conference Dec 17 2014
Teva Upgraded On Strength Of Copaxone MS Drug Dec 12 2014
MiMedx Group, Conn's, Mylan, Pfizer and Amgen highlighted as Zacks Bull and Bear of the Day Dec 12 2014
Mylan Among First to Launch Generic Celebrex Dec 11 2014
Teva Pharm sees 2015 revenue lower than forecast Dec 11 2014
Mylan Launches Generic Robaxin® Injection Dec 11 2014
Mylan Launches First Generic Version of Orapred ODT® Dec 11 2014
Mylan Launches Generic Robaxin® Injection Dec 11 2014
Mylan Launches First Generic Version of Orapred ODT® Dec 11 2014
Mylan pays bonuses to ease 'spinversion' Dec 10 2014
Mylan Launches One of First Available Generic Versions of Celebrex® Capsules Dec 10 2014
Merck-Cubist Deal Is On Despite Patent Setback Dec 09 2014
Two Gauges That Point To Fund Buying In A Stock Dec 08 2014
World TeamTennis and Mylan Announce Title Sponsorship Extension Through 2017 Dec 08 2014
World TeamTennis and Mylan Announce Title Sponsorship Extension Through 2017 Dec 08 2014
Medical Issues Keep Climbing Into Sell Zone Dec 04 2014
GlaxoSmithKline scraps £7bn sale of old drugs Dec 04 2014
Mylan receives tentative FDA approval for paediatric formulations of abacavir/lamivudine through... Dec 04 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK